Custom mRNA Synthesis

Creative Biolabs is a trusted partner in mRNA services. With decades of experience in mRNA research and development, our scientists can provide both chemical synthesis approach and IVT synthesis strategy to meet the unique requirements of every client.

LPR Technology

LPR technology modifies the mRNA encoding a wide variety of tumor antigens by specific histidylated liposomes and polymers to boost the mRNA delivery more safely and effectively.

Services

Services of mRNA therapeutics development at Creative Biolabs covers all key steps in therapeutic nucleic acids development, including chemical and enzymatic synthesis and modifications, formulation and delivery system development, in vitro tests, and in vivo tests.

READ MORE...

Custom mRNA Synthesis

Creative Biolabs provides both chemical synthesis and IVT synthesis strategy of mRNA to meet the unique requirements of every client.

Custom Lipid Nanoparticle Encapsulation

In recent years, mRNA has attracted much attention as a multifunctional therapeutic agent, and it has the potential to prevent and treat various diseases.

Custom mRNA-based Cell Reprogramming Service

Creative Biolabs provides comprehensive solutions for mRNA-based reprogramming to deliver high-quality iPSCs cell lines to meet your specific needs.

One-stop mRNA Therapeutics Development

The novel messenger ribonucleic acid (mRNA) therapeutics strategies have aroused great attention in many clinical settings, such as cancer treatment.

Call To Action

If you have any specific request on mRNA that is not within the scope of services described, please feel free to drop us a call or send us an email to for further discussion with our scientists.

About Us

Creative Biolabs will keep devoting our time and effort in establishment and optimization of platforms enabling various therapeutics nucleic acid development in a wide range of indications.

With the significant progressing of scientific research and numerous ongoing pre-clinical development, mRNA has become a promising therapeutics modality for various indications including cancers and infectious diseases.

During developments of mRNA therapeutics, the stability and translation efficiency remains two pivotal issues at early stage and may have influences throughout the overall development

processes even the large scale manufacture and they need to be addressed as early as possible. To this end, Creative Biolabs has developed a comprehensive platform enabling optimization of mRNA synthesis, modification, and delivery method.

Latest Content For Researchers

Contact Us
USA

Tel:

UK

Tel:

Germany

Tel:

webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW